John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Signet Jewelers
SIG
$3.16B
| $8.96M | 0.04% |
+64,567
| New | +$8M |
|
|
ANN
502
DELISTED
ANN INC
ANN
| $8.95M | 0.04% |
+218,093
| New | +$7.98M |
|
|
CRZO
503
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $8.91M | 0.04% |
+179,377
| New | +$8.39M |
|
|
DRII
504
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $8.91M | 0.04% |
266,393
+117,707
| +79% | +$3.7M |
|
|
HME
505
DELISTED
HOME PROPERTIES, INC
HME
| $8.89M | 0.04% |
128,278
+91,628
| +250% | +$6.34M |
|
506
Motorola Solutions
MSI
$79.5B
| $8.88M | 0.04% |
+133,218
| New | +$8.81M |
|
507
PTC
PTC
$16.8B
| $8.88M | 0.04% |
245,397
+85,145
| +53% | +$2.94M |
|
|
TRNX
508
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $8.86M | 0.04% |
338,017
-25,267
| -7% | -$640K |
|
509
Fossil Group
FOSL
$332M
| $8.86M | 0.04% |
+107,394
| New | +$9.88M |
|
510
ProShares Ultra QQQ
QLD
$13.9B
| $8.85M | 0.04% |
1,987,200
+1,699,200
| +590% | +$7.49M |
|
511
John Wiley & Sons Class A
WLY
$2.62B
| $8.84M | 0.04% |
+144,600
| New | +$8.88M |
|
|
SAVE
512
DELISTED
Spirit Airlines, Inc.
SAVE
| $8.79M | 0.04% |
113,585
-166,624
| -59% | -$12.8M |
|
513
Kinross Gold
KGC
$38.9B
| $8.77M | 0.04% |
3,917,165
-2,353,282
| -38% | -$6.85M |
|
514
Terex
TEX
$7.6B
| $8.77M | 0.04% |
329,885
+34,382
| +12% | +$869K |
|
515
Nexstar Media Group
NXST
$5.73B
| $8.75M | 0.04% |
152,974
-55,014
| -26% | -$2.92M |
|
516
Xcel Energy
XEL
$47.7B
| $8.75M | 0.04% |
+251,381
| New | +$8.99M |
|
|
AEC
517
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
| $8.68M | 0.04% |
351,773
-24,937
| -7% | -$611K |
|
518
Nice
NICE
$5.87B
| $8.63M | 0.04% |
141,645
+54,890
| +63% | +$3.02M |
|
519
Northwest Bancshares
NWBI
$2.26B
| $8.56M | 0.04% |
722,816
+546,790
| +311% | +$6.5M |
|
520
Brookfield
BN
$93.1B
| $8.56M | 0.04% |
+683,393
| New | +$8.47M |
|
521
PUT
JPMorgan Chase
JPM
$935B
| $8.54M | 0.04% |
+141,000
| New | +$8.35M |
|
|
ABMD
522
DELISTED
Abiomed Inc
ABMD
| $8.51M | 0.04% |
118,926
-16,132
| -12% | -$876K |
|
|
PRMW
523
DELISTED
Primo Water Corporation
PRMW
| $8.5M | 0.04% |
907,612
+35,810
| +4% | +$302K |
|
|
HT
524
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $8.5M | 0.04% |
328,461
+102,845
| +46% | +$2.76M |
|
525
Emcor
EME
$34.3B
| $8.48M | 0.04% |
182,570
+88,946
| +95% | +$3.86M |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.